CNTB - Company ID 0001835268
The table below shows Connect Biopharma Holdings Ltd's income statement line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $64.00K | $26.03M | $0.00 | - | - |
| Cost of revenue | - | - | - | - | - |
| Gross profit | - | - | - | - | - |
| R&D | $37.80M | $29.26M | $53.00M | $96.63M | $80.50M |
| SG&A | $20.34M | $19.23M | $16.05M | - | - |
Connect Biopharma Holdings Ltd reported annual revenue of $64.00K for fiscal year 2025. That is down 99.8% from $26.03M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Operating income |
| -$58.07M |
| -$22.45M |
| -$69.06M |
| - |
| - |
| Income tax | $197.00K | $223.00K | $120.00K | - | - |
| Net income | -$55.48M | -$15.63M | -$62.11M | - | - |
| EPS (diluted) | -$1.00 | -$0.28 | -$1.13 | - | - |